Serna Bio will be provided free lab space for one year in the state-of-the-art MBC BioLabs laboratory facility enabling them to pursue drug discovery and innovation for the potential future benefit of patients worldwide.

Entries were received across a broad range of disease areas and included a number of exciting, innovative technologies. Serna Bio was selected based on AI enabled RNA drug discovery platform, which opens up target space inaccessible to classical small molecule drug discovery.